Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sleep Wake Disorders × exemestane × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 186 Neoplasm Metastasis 17 Breast Neoplasms, Male 6 Neoplasms 4 Breast Diseases 4 Obesity 3 Carcinoma, Intraductal, Noninfiltrating 3 Breast Carcinoma In Situ 3 Breast Cancer Metastatic 3 Recurrence 2 Bulbo-Spinal Atrophy, X-Linked 2 Arthralgia 2 Advanced Breast Cancer 2 Vitamin D Deficiency 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sleep Wake Disorders 1 Skin Diseases 1 Primary Breast Cancer ER+ve 1 Premenopausal Breast Cancer 1 Post Menopausal Women With Early Breast Cancer 1 Pain 1 Ovarian Neoplasms 1 Nutrition Disorders 1 Neoplasms by Site 1 Multiple Endocrine Neoplasia Type 1 1 Locoregional Recurrence 1 Kidney Neoplasms 1 Invasive Early Breast Cancer 1

Interventions

Yoga 2 Tamoxifen 2 Educational Status 2 exemestane 1 Zolpidem 1 Venlafaxine Hydrochloride 1 Triptorelin Pamoate 1 Therapeutics 1 Psychiatric Rehabilitation 1 Methods 1 Metformin 1 Gonadotropin-Releasing Hormone 1 Early Intervention, Educational 1 Donepezil 1 Behavior Therapy 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00659373 2016-07-25

Co-SOFT

ETOP IBCSG Partners Foundation

Phase 3 Completed

86 enrolled 4 charts

Breast Neoplasms, Fatigue, Sleep Wake Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡